..., instructions or products referred to in the content or advertisements. 2023 SGLT2 inhibitors Kidney transplant Diabetes mellitus Hypertension Cardiovascular disease (CVD) is a major cause of graft loss and the leading cause of death in renal transplant recipients (RTRs), accounting for 30...

...Daniel Khan; Nan Zhang; Bassam G. Abu Jawdeh; Sundararaman Swaminathan; Sumi Nair; Mira T. Keddis Introduction: This study describes patient characteristics and examines graft function of kidney transplant recipients (without primary hyperoxaluria) with elevated plasma oxalate (POx) and enteric...

... increases urinary copper excretion, inducing oxidative tubular damage and worsening kidney function. We investigated whether this phenomenon occurred in kidney transplant recipients (KTRs). In addition, we studied the associations of urinary copper excretion with the biomarker of oxidative tubular damage...

... Global epidemiology End-stage kidney disease Kidney replacement therapy Dialysis Hemodialysis Peritoneal dialysis Kidney transplant Disparities Income Mortality NIH End-stage kidney disease (ESKD) is a rapidly increasing global health and health care burden. The inability...

...Rushad Machhi; Didier A. Mandelbrot; Talal Al-Qaoud; Brad C. Astor; Sandesh Parajuli Background: The incidence of renal cell carcinoma (RCC) is higher in kidney transplant recipients (KTRs) compared to the general population. However, the risk factors and outcomes based on the diagnosis of RCC...

...Christine Firth; Tripta Kaur; Harini Chakkera; Nan Zhang; Fadi Shamoun; Eric Steidley; Raymond Heilman; Mira Keddis Background: Patients presenting for kidney transplant (KTx) evaluation are subject to high rates of mortality and cardiovascular (CV) events pre- and post-KTx. CV and mortality risk...

..., instructions or products referred to in the content or advertisements. Visual Abstract Visual Abstract. Vascular calcification Cardiovascular disease Kidney transplant Simultaneous pancreas-kidney transplant Mortality Patients with chronic kidney disease (CKD) have increased...

...Ahmed A. Awan; Jingbo Niu; Jenny S. Pan; Kevin F. Erickson; Sreedhar Mandayam; Wolfgang C. Winkelmayer; Sankar D. Navaneethan; Venkat Ramanathan Background: Death with graft function remains an important cause of graft loss among kidney transplant recipients (KTRs). Little is known about the trend...

... kidney transplantation. Methods: We reviewed a cohort of 764 kidney transplant recipients and analyzed pertinent cardiovascular risk factors at the time of transplant evaluation. Proportional hazards regression analysis with bootstrapping method was utilized to provide a risk stratification score...

...Donald F. Chute; Meghan E. Sise Background: The opioid crisis has led to a dramatic increase in the number of drug overdose deaths in the United States. Little is known about the effect of the opioid crisis on the kidney transplant donor pool, particularly on hepatitis C virus (HCV)-infected donors...

...%) or Non-Hispanic black (31.7%). Of these, 140 patients (84.0%) reported discussing kidney transplantation with their doctor but only 53% reported having a transplant evaluation. After adjustment for age, gender, and time on dialysis, significantly fewer blacks reported having an evaluation than Non...

... 1.4-1.8, p < 0.0001). Table 1 Baseline characteristics compared between the appointment adherent and appointment non-adherent cohorts for the population with complete data Between January 2001 and December 2007, 5,757 veteran kidney transplant patients receiving care through the VA...

...Akhil Sharma; Jonathan Yabes; Saleem Al Mawed; Christine Wu; Carol Stilley; Mark Unruh; Manisha Jhamb Background: Limited evidence from small-scale studies, mainly involving end-stage renal disease (ESRD) patients, suggests that kidney transplantation may improve cognitive function. We examined...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Obesity Kidney transplant Outcomes A worldwide epidemic of obesity has contributed to a rise in kidney disease over the past decade...

... in RTR with high CRCRTR-MACE, particularly in smokers with diminished eGFR. Circulating TPO may serve as a biomarker and treatment target for CVD in RTR. The study was approved by the regional ethics board (Bio #11-220). All stable kidney transplant patients (17 years or older) followed in one out...

... systematically examined in kidney transplant recipients. We aimed to determine the frequency of metformin use and its associations among kidney transplant recipients, and to assess allograft and patient survival associated with metformin use. Methods: In this retrospective cohort study, we linked Scientific...

... routine screening during pre-kidney transplant evaluation. RCC must be quiescent prior to kidney transplantation. However, the tumor-free waiting period for RCC varies depending on the types of RCC. Multilocular cystic RCC (MCRCC), one subtype of clear cell RCC, has low malignant potential and may...

...Lalitha De Silva; Clarissa J. Diamantidis; Divya Prakash; Marni Zuckerman; Matthew R. Weir Background and Objectives: Kidney transplant recipients are at increased risk for adverse safety events related to reduced renal function and polypharmacy. Health information technology tools have...

...Giuseppe Cianciolo; Irene Capelli; Maria Laura Angelini; Chiara Valentini; Olga Baraldi; Maria P. Scolari; Sergio Stefoni Background: Kidney transplantation is the treatment of choice for chronic kidney disease (CKD), but in kidney transplant recipients (KTRs) cardiovascular events are the first...

... as antihypertensives in kidney transplantation (KTX). Methods: This was a longitudinal retrospective cohort study conducted in adult KTX recipients. Patients were grouped based on receiving thiazides following KTX. Safety and efficacy comparisons were made between thiazide recipients and unexposed patients, as well...